MannKind Corp. has earned a $50 million milestone payment under its collaboration and licensing agreement with Sanofi in connection with the satisfaction of manufacturing milestones for Afrezza.   MannKind had received a $150 million upfront payment and is eligible to earn as much as $725 million in further development, regulatory and sales milestones, and is also eligible to receive a share of profits on Afrezza sales....